Lesson 26
Lesson 26
26
Notes
HEMOLYTIC DISEASE OF THE
NEW BORN (HDNB)
26.1 INTRODUCTION
Hemolytic disease of the newborn is a condition in which IgG antibodies from
maternal blood cross the placenta into the fetal circulation where they react with
fetal red cells and break them.
OBJECTIVES
After reading this lesson, you will be able to:
z explain the pathology of Hemolytic disease of the newborn
z discuss the antenatal assessment of Hemolytic Disease of Newborn
z describe the tests on maternal and cord blood at delivery
z explain the prophylaxis for hemolytic disease of new born
26.2 PATHOPHYSIOLOGY
Hemolytic disease of the newborn is a condition which occurs due to destruction
of fetal red cells by IgG antibodies from maternal blood. The antibodies cross
the placenta during pregnancy and reach into the circulation of the fetus where
they react with the red blood cells and break them. These antibodies are
commonly directed against Rh or ABO blood group antigens on fetal red cells.
The ABO incompatibility is much more common than Rh but is usually of less
severity. The antibodies are usually of the IgM type (which cannot cross the
placenta). IgG antibodies are more likely to occur when mother of blood group
“O” carries fetus of either group A or B. The ABO incompatibility may be seen
even in first pregnancy, but it is very less severe than Rh incompatibility because:
1. The fetal red cells express A&B blood group antigens weakly.
2. There is widespread distribution of carbohydrate antigens in fetal fluids &
tissues which mimic A and B red cell antigens and neutralize large part of
maternal anti-A and anti-B antibody.
Anti D Prophylaxis
Anti D is administered to Rh negative women during pregnancy and after
delivery or abortion to minimize the risk of HDNB.
TERMINAL QUESTIONS
1. Explain the tests on maternal and cord blood at delivery
2. Explain briefly the pathogenesis of Hemolytic disease of Newborn
26.1
1. ABO & Rh
2. Negative, Positive
3. O, A or B
4. Anti D titre
5. Kleihaurer- Betke test